Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape

Over the last several decades, a number of new treatment options for patients with hepatocellular carcinoma (HCC) have been developed. While treatment decisions for some patients remain clear cut, a large numbers of patients have multiple treatment options, and it can be hard for multidisciplinary t...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Shamar, Hannallah, Jack, Goldberg, Dan, Sanghvi, Tina, Arshad, Junaid, Scott, Aaron, Woodhead, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380625/
https://www.ncbi.nlm.nih.gov/pubmed/37511193
http://dx.doi.org/10.3390/ijms241411434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380625/
https://www.ncbi.nlm.nih.gov/pubmed/37511193
http://dx.doi.org/10.3390/ijms241411434

Ejemplares similares